Comparison results
| Results: Differences General | ✘Poikiloderma | ✘Best's disease | ||||
| Related research | Analogs | Analogs | ||||
| ||||||
| Distinctive symptoms | ||||||
| Register, to see more distinctive signs of diseases and studies | 99% | — | ||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||
| skin atrophy | 66% | — | ||||
| poor sleep | — | 49% | ||||
| parapsoriasis | 63% | — | ||||
| retinal dystrophy | — | 43% | ||||
| papules | 49% | — | ||||
| visual impairment | — | 42% | ||||
| patient's condition | 45% | — | ||||
| cysts | — | 41% | ||||
| parchment skin | 42% | — | ||||
| up vascular mesh | — | 40% | ||||
| liebman-sachs endocarditis | 40% | — | ||||
| scotoma | — | 39% | ||||
| red lichen planus | 39% | — | ||||
| angiopathy of the retina | — | 38% | ||||
| there is a fever in the whole body | 38% | — | ||||
| blurred vision | — | 36% | ||||
| fungal mycosis | 38% | — | ||||
| sleeps with light | — | 36% | ||||
| endocarditis | 38% | — | ||||
| loss of visual fields | — | 36% | ||||
| onychodystrophy | 37% | — | ||||
| sharpness decreased vision | — | 36% | ||||
| thin hair | 37% | — | ||||
| does not sleep one | — | 34% | ||||
| main complaint is high fever | 36% | — | ||||
| central choreoretinal dystrophy | — | 32% | ||||
| dermatomyositis | 36% | — | ||||
| itchy eyes | — | 29% | ||||
| fungal skin lesion | 34% | — | ||||
| rupture of the eyeball | — | 27% | ||||
| lymphogranulomatosis | 34% | — | ||||
| progressive myopia | — | 27% | ||||
| history of surgery | 34% | — | ||||
| peak's disease | — | 26% | ||||
| from eating better | 33% | — | ||||
| chatty | — | 26% | ||||
| rashes with peeling | 33% | — | ||||
| roth's disease | — | 26% | ||||
| red hands | 33% | — | ||||
| retinal hemorrhage | — | 26% | ||||
| lichen | 33% | — | ||||
| scarring | — | 26% | ||||
| dermatomycosis | 33% | — | ||||
| does not sleep at night | — | 25% | ||||
| skin lymphoma | 33% | — | ||||
| bright eyes | — | 25% | ||||
| feeling of bruising | 33% | — | ||||
| shroud | — | 24% | ||||
| face is red | 32% | — | ||||
| impaired arterial function | — | 23% | ||||
| feeling of heat | 32% | — | ||||
| myopia | — | 23% | ||||
| systemic scleroderma | 31% | — | ||||
| hemorrhage in the eye | — | 23% | ||||
| high temperature | 31% | — | ||||
| dementia | — | 22% | ||||
| red legs | 31% | — | ||||
| gradual deterioration of the condition | — | 19% | ||||
| lymphocytosis | 31% | — | ||||
| vascular tumor | — | 19% | ||||
| frequent antibiotics | 31% | — | ||||
| subacute condition | — | 18% | ||||
| systemic lupus erythematosus | 30% | — | ||||
| there are no complaints | — | 16% | ||||
| purulent rashes on the skin | 30% | — | ||||
| dystrophy | 24% | 37% | ||||
| hyperpigmentation | 30% | — | ||||
| oncology | 14% | 22% | ||||
| onset of illness | 30% | — | ||||
| angiopathy | 22% | 29% | ||||
| bruise | 29% | — | ||||
| lowered | 20% | 26% | ||||
| peeling | 29% | — | ||||
| malignant lymphoma | 29% | — | ||||
| skin cancer | 28% | — | ||||
| lymphoma | 28% | — | ||||
| small rash | 28% | — | ||||
| illness after hypothermia | 28% | — | ||||
| rash pustules | 28% | — | ||||
| low body temperature | 28% | — | ||||
| very correct | 28% | — | ||||
| cataract | 28% | — | ||||
| fungus | 27% | — | ||||
| feeling the heat in the skin | 27% | — | ||||
| open person | 27% | — | ||||
| worse from the heat | 27% | — | ||||
| pedantry | 26% | — | ||||
| intolerance to drugs | 26% | — | ||||
| reddening of the skin | 26% | — | ||||
| family man | 25% | — | ||||
| suppuration of the skin | 25% | — | ||||
| not enough time | 24% | — | ||||
| drug allergy | 24% | — | ||||
| increased sensitivity | 23% | — | ||||
| presses | 23% | — | ||||
| increased alt | 92% | 70% | ||||
| consequences of taking medications | 20% | — | ||||
| skin spots | 51% | 34% | ||||
| skin problems | 46% | 32% | ||||
| brown pigmentation after rashes | 49% | 37% | ||||
| brown spots on the skin | 48% | 37% | ||||
| s eyes cloudy | 27% | 21% | ||||
| drug disease | 21% | 16% | ||||
| increased | 19% | 15% | ||||
Instructions
Video 
|
